Registration Opens for the Common Sense Oncology India Hub to Discuss Appraisal of the ALASCCA Trial

Common Sense Oncology shared a post on LinkedIn:

“We invite those from India and beyond to join us for the second webinar of the Common Sense Oncology India Hub!

Join us on Wednesday, January 21, 2026, at 7:00 pm India Standard Time to learn more about CSO and discuss a critical appraisal of the ALASCCA trial (low dose aspirin for colon cancer trial).